Clinical Trials Directory

Trials / Completed

CompletedNCT02726620

Decision Support for Intraoperative Low Blood Pressure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22,435 (actual)
Sponsor
Vanderbilt University Medical Center · Academic / Other
Sex
All
Age
60 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a decision support system can improve the adherence to thresholds for low blood pressure by anesthesia providers, which in turn prevents their patients from having organ injury.

Detailed description

Blood pressure management is an important part of anesthesia. Many factors contribute to a change in blood pressure during a surgical procedure, such as blood loss, manipulation by surgeons, and there are several mechanisms through which anesthesia itself changes blood pressure. Although a high blood pressure also occurs during anesthesia, most of these factors lower a patient's blood pressure. When a patient's blood pressure becomes too low, the internal organs become at risk of receiving not enough blood (low perfusion or hypoperfusion). This low perfusion state can result in organ damage (ischemia) because of an insufficient supply of oxygen and glucose. Hence the important task of anesthesia providers to maintain the blood pressure of patients, using a wide range of drugs and other interventions. A big challenge in blood pressure management is to know when a low blood pressure indeed results in low perfusion of organs. There is a large variation between patients in how susceptible they are to low blood pressure, as well as a difference between the organs in how easily they are damaged because of low perfusion. Elder patients, or patients with preexisting hypertension, heart problems or other cardiovascular diseases are more prone to a low blood pressure and are more likely to develop organ ischemia when there is a low blood pressure. The kidneys, the heart and the brain are the organs that are most at risk of organ damage. As one cannot measure the perfusion states of individual organs in individual patients, it is very difficult to know 'how low to go' with a patient's blood pressure. Recent studies have used large datasets of patients to demonstrate that there is statistical association between low blood pressure during surgery and various types of organ injury. As patients are already treated for low blood pressure by anesthesia providers, this suggests that patients have low organ perfusion states despite the current treatment standards. A patient's blood pressure is not simply a dial that can be adjusted to a specific level. Finding the right level of interventions can be difficult in some patients. Consequently, lower blood pressures are common in anesthesia, even with the current standards of blood pressure management. In this proposed study the investigators will implement two forms of decision support to assist anesthesia providers in blood pressure management. The decision support aims to educate anesthesia providers about the risks of low blood pressures in direct relation to the patients that they treat. One form of decision support will provide automated notifications through pagers and through the anesthesia information management system. These automated notifications pop up when the patient's blood pressure drops below a level that is associated with a risk of organ injury, and thus alerts the anesthesia provider of the blood pressure and its associated risk. The second form of decision support will send a postoperative email the day after the procedure when the patient has had a low blood pressure for particular duration. This email then provides feedback to the anesthesia provider by informing them of the increased risks of organ injury that are associated with that low blood pressure. The study will look at both a change in patient outcome and a change in blood pressure management and will be performed at the Vanderbilt University Medical Center (VUMC). The change in patient outcome will primarily be studied through the occurrence of acute kidney injury in the first days following the procedure at the VUMC. The change in blood pressure management (provider behavior) will be studied by observing the depth and duration of low pressures during anesthesia, and the number of interventions that have been used to treat the blood pressure. Patient outcome will be studied by comparison of a baseline phase - before the decision support is implemented and uses historic data- and the intervention phase - the period during which the intervention is active. Only routinely collected clinical data will be used for these analyses: no additional data collection is required. As it is impossible to know which form of decision support will be the most effective, the first three months of the intervention period will be a 'nested cluster-randomized trial'. The anesthesia providers (not the patients) will be randomized to either the automated notifications or the feedback emails. After three months all anesthesia providers will receive both forms of decision support for the remainder of the intervention period. The reason why anesthesia providers are randomized only during the first three months is that cross-over or contamination between the two groups is expected. This contamination could make it impossible to study the effect of the decision support on patient outcome, as there will be no longer any difference between the study groups.

Conditions

Interventions

TypeNameDescription
PROCEDUREAttending real-time decision supportNear real-time decision support elements will notify the attending anesthesiologists of a blood pressure drop below the threshold for intraoperative hypotension (mean arterial pressure below 60 mmHg). The notification is presented through the pager system. The page will also display the associated increased risk of organ injury due to organ ischemia.
PROCEDUREIn-room real-time decision supportNear real-time decision support elements will notify the in-room anesthesia provider of a blood pressure drop below the threshold for intraoperative hypotension (mean arterial pressure below 60 mmHg). The notification is presented through the anesthesia information management system. The decision support system will display the associated increased risk of organ injury due to organ ischemia.
PROCEDUREAttending feedback emailsAttending anesthesiologists will be notified through email within 24 hours after the end of an anesthetic case, when the patient had an episode of intraoperative hypotension (mean arterial pressure below 60 mmHg or lower for a particular duration) that is associated with an increased risk of organ injury due to organ ischemia.
PROCEDUREIn-room provider feedback emailsIn-room anesthesia providers will be notified through email within 24 hours after the end of an anesthetic case, when the patient had an episode of intraoperative hypotension (mean arterial pressure below 60 mmHg or lower for a particular duration) that is associated with an increased risk of organ injury due to organ ischemia.
DEVICEAnesthesia Information Management System (AIMS)The anesthesia electronic record keeping system
DEVICEPerioperative Data Warehouse (PDW)The data warehouse that is used to gather perioperative data and create user reports. In this instance the PDW will be used to send the postoperative feedback emails.
PROCEDUREGeneral anesthesiaAny anesthetic drugs that are used to induce general anesthesia above the level of sedation.
DEVICEPager systemThe mobile pager system through which alerts can be sent
PROCEDURECentral neuraxial anesthesiaRegional anesthesia effectuated through the placement of local anesthetics around the nerves of the central nervous system, e.g. spinal anesthesia and epidural anesthesia.
PROCEDURENon-cardiac surgeryAny surgical intervention that is not aimed at surgical correction of the heart
DRUGPropofolAnesthetic drug used to maintain general anesthesia
DRUGSevofluraneAnesthetic drug used to maintain general anesthesia
DRUGDesfluraneAnesthetic drug used to maintain general anesthesia
DRUGIsofluraneAnesthetic drug used to maintain general anesthesia
DRUGEphedrineCardiovascular drug used to treat intraoperative hypotension
DRUGPhenylephrineCardiovascular drug used to treat intraoperative hypotension
DRUGNorepinephrineCardiovascular drug used to treat intraoperative hypotension
DRUGEpinephrineCardiovascular drug used to treat intraoperative hypotension
DRUGDobutamineCardiovascular drug used to treat intraoperative hypotension
DRUGDopamineCardiovascular drug used to treat intraoperative hypotension
DRUGIsoproterenolCardiovascular drug used to treat intraoperative hypotension
DRUGMilrinoneCardiovascular drug used to treat intraoperative hypotension
DRUGAtropineCardiovascular drugs used to treat intraoperative hypotension
DRUGGlycopyrrolateCardiovascular drug used to treat intraoperative hypotension
DRUGVasopressinCardiovascular drug used to treat intraoperative hypotension
DRUGTerlipressinCardiovascular drug used to treat intraoperative hypotension
DRUGSodium Chloride 0.9%Intravenous fluid used to treat intraoperative hypotension
DRUGRinger's lactateIntravenous fluid used to treat intraoperative hypotension
DRUGHydroxyethyl starch solutionsIntravenous fluid used to treat intraoperative hypotension
DRUGFresh Frozen PlasmaIntravenous fluid used to treat intraoperative hypotension
DRUGPacked Red Blood CellsIntravenous fluid used to treat intraoperative hypotension
DRUGAlbumin solutionsIntravenous fluid used to treat intraoperative hypotension
DRUGPlasma-LyteIntravenous fluid used to treat intraoperative hypotension
DRUGLidocaineLocal anesthetic used for central neuraxial anesthesia.
DRUGBupivacaineLocal anesthetic used for central neuraxial anesthesia.
DRUGLevobupivacaineLocal anesthetic used for central neuraxial anesthesia.
DRUGRopivacaineLocal anesthetic used for central neuraxial anesthesia.
DRUGMepivacaineLocal anesthetic used for central neuraxial anesthesia.
DRUGTetracaineLocal anesthetic used for central neuraxial anesthesia.
DRUGPrilocaineLocal anesthetic used for central neuraxial anesthesia.
DRUGProcaineLocal anesthetic used for central neuraxial anesthesia.
DRUGChloroprocaineLocal anesthetic used for central neuraxial anesthesia.
DRUGBenzocaineLocal anesthetic used for central neuraxial anesthesia.
DRUGArticaineLocal anesthetic used for central neuraxial anesthesia.

Timeline

Start date
2017-01-05
Primary completion
2017-12-31
Completion
2018-12-29
First posted
2016-04-04
Last updated
2019-05-16
Results posted
2019-05-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02726620. Inclusion in this directory is not an endorsement.